Ahabir 500mg Tablet

Ahabir 500mg tablet is a hormonal therapy specifically in an anti- androgen or androgen biosynthesis inhibitor used to treat advanced or metastatic castration- resistant prostate cancer (mCRPC) in adult men. It contains Abiraterone Acetate as its active ingredient which works by blocking the enzyme CYP17 that play a crucial role in the biosynthesis of androgen in the testes, adrenal glands and prostate cancer tumor tissues. Strict guidelines should be follow regarding its administrations, monitoring and to ensure safety and therapeutic effectiveness of the medications.

Prostate cancer

Ahabir 500mg tablet also causes common as well as severe side effects, some of the symptoms may resolve on their own any some need proper medication to treat. Consult the doctor is trhe symptoms persist:
● Diarrhea
● High-fat levels in the blood
● Chest pain
● Irregular heartbeat
● Rapid heart rate
● Fluid in legs or feet
● Low blood potassium
● High blood pressure
● Urinary tract infection
● Bone fracture
● Indigestion
● Blood in urine
● Rash

Ahabir 500mg tablet must be taken on an empty stomach or at least one hour before and 2 hours after the food. Try to take it once daily to enhance the effectiveness of the medication. In case of an overdose of the tablet, consult the doctor but do not taken on missed one. The medicine is used in other combination of medication with low dose corticosteroids to reduce the risk of side effects and improve treatment outcomes.

CYP17 is an enzyme that produces steroid hormones like androgen (Testosterone) which is responsible for the growth and multiplication of cancer cells in the body. Ahabir 500mg suppresses androgen production by blocking CYP17 enzyme and limits its driven growth and proliferation of prostate cancer cells. This mechanism help slow disease progression in patients whose cancer continue to grow, helping to manage the symptoms and improve clinical outcomes.

• Murtaza, G., Khan, S. A., Shabbir, A., Mahmood, A., Asad, M. H. H. B., Farzana, K., ... & Hussain, I. (2011). Development of a UV-spectrophotometric method for the simultaneous determination of aspirin and paracetamol in tablets. Scientific research and Essays, 6(2), 417-421.
• Gul, M., Liu, Z. W., Rabail, R., Faheem, F., Walayat, N., Nawaz, A., ... & Aadil, R. M. (2022). Functional and nutraceutical significance of amla (Phyllanthus emblica L.): A review. Antioxidants, 11(5), 816.
• Shabir, G. A., & Arain, S. A. (2011). Determination of paracetamol, methyl parahydroxybenzoate, ethyl parahydroxybenzoate, and propyl parahydroxybenzoate in medicinal suspension and tablets by rplc/uv-dad. Journal of liquid chromatography & related technologies, 34(9), 719-729.
• Mehmood, A., Tahir, S., Shabbir, A., Khalid, N., Salman, A., & Hanif, F. (2021). Pharmaceutical Effects on Placental Morphology in Women with Gestational Diabetes Mellitus.
• Shabbir, M. S. M., Kalam, S. I., Ahmad, A., Khan, G. J., Moiz, M., & Shaikh, A. (2025). Fast Dissolving Tablets: A Comprehensive Review. International Journal of Research in Pharmacy and Allied Science, 3(6), 100-108.